Fig. 1.

Immune conditions are associated with AML clinical features. a, b Distribution of immune scores and stromal scores for AML subtypes. c The significant correlation between immune scores and AML cytogenetic risk (p = 0.0396). d The stromal scores show no significant difference in cytogenetic risk (p = 0.8585). e Kaplan-Meier survival curve reveals that higher immune scores are associated with significantly shorter overall survival (log-rank test, p = 0.0273). f The low stromal score group showed a longer median overall survival than high stromal score group, with no significant difference (log-rank test, p = 0.4706)